Amundi Buys 9,207 Shares of Plexus Corp. (NASDAQ:PLXS)

Amundi increased its stake in Plexus Corp. (NASDAQ:PLXSFree Report) by 192.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,000 shares of the technology company’s stock after buying an additional 9,207 shares during the period. Amundi owned 0.05% of Plexus worth $2,289,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Quarry LP raised its stake in Plexus by 573.5% in the third quarter. Quarry LP now owns 229 shares of the technology company’s stock worth $31,000 after buying an additional 195 shares in the last quarter. R Squared Ltd bought a new position in Plexus in the fourth quarter worth about $45,000. USA Financial Formulas bought a new position in Plexus in the fourth quarter worth about $56,000. Point72 DIFC Ltd bought a new position in Plexus in the third quarter worth about $51,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Plexus in the third quarter worth about $55,000. 94.45% of the stock is owned by institutional investors.

Insider Activity at Plexus

In other Plexus news, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $145.14, for a total value of $496,814.22. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $4,281,775.14. The trade was a 10.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total transaction of $234,585.00. Following the completion of the sale, the chief executive officer now owns 74,271 shares in the company, valued at approximately $11,615,241.69. The trade was a 1.98 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 19,458 shares of company stock worth $2,786,515. 1.76% of the stock is owned by corporate insiders.

Plexus Trading Up 0.8 %

NASDAQ:PLXS opened at $125.16 on Tuesday. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $172.89. The company has a market cap of $3.38 billion, a PE ratio of 29.04 and a beta of 0.90. The company has a 50 day simple moving average of $142.87 and a two-hundred day simple moving average of $145.66.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. Research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on PLXS shares. Stifel Nicolaus began coverage on shares of Plexus in a research note on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price target for the company. Benchmark restated a “buy” rating and issued a $165.00 price objective on shares of Plexus in a report on Wednesday, January 22nd. StockNews.com upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Monday, November 18th. Finally, Needham & Company LLC upped their price objective on shares of Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Plexus presently has an average rating of “Moderate Buy” and a consensus price target of $163.00.

View Our Latest Analysis on Plexus

About Plexus

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.